Cost-effectiveness of colorectal cancer screening strategies: A systematic review.
colorectal cancer
cost-effectiveness
screening
systematic review
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
30
04
2022
received:
08
01
2022
accepted:
24
06
2022
pubmed:
17
8
2022
medline:
30
11
2022
entrez:
16
8
2022
Statut:
ppublish
Résumé
Colorectal cancer (CRC) is the second leading cause of death worldwide and the use of CRC screening tests can reduce the incidence and mortality of the disease by early detection. This study aims to review cost-effectiveness strategies in different ages and countries, systematically. We searched ProQuest, Web of Science, Scopus, Cochrane, PubMed and Embase for related studies between 2010 and 2020. Articles that reported costs per Quality-Adjusted Life Year or Life Year Gain and Incremental Cost-Effectiveness Ratios to compare the cost-effectiveness of CRC screening strategies in the average-risk population were included in our study. The search strategies identified 426 records and finally 48 articles were included in the systematic review based on included and excluded criteria. We identified seven strategies for CRC screening. Most of the strategies were performed in aged 50-75. These studies were reported by cost per Quality-Adjusted life year (QALY)/Life Year Gain (LYG) based on methods and perspectives and the ICER of comparison of two-by-two strategies. Most of the CRC screening strategies were cost-effective, but there was big heterogeneity between the cost-effectiveness analysis of CRC screening strategies because of different screening methods, perspectives and screening populations. So, it is important to consider this heterogeneity to compare the economic evaluation studies in this field.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Pagination
e13673Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Azad, N. S., Leeds, I. L., Wanjau, W., Shin, E. J., & Padula, W. V. J. (2020). Cost-utility of colorectal cancer screening at 40 years old for average-risk patients. Preventive Medicine, 133, 106003. https://doi.org/10.1016/j.ypmed.2020.106003
Barichello, S., Deng, L., Ismond, K. P., Loomes, D. E., Kirwin, E. M., Wang, H., Chang, D., Svenson, L. W., & Thanh, N. X. J. (2019). Comparative effectiveness and cost-effectiveness analysis of a urine metabolomics test vs. alternative colorectal cancer screening strategies. International Journal of Colorectal Disease, 34(11), 1953-1962.
Barouni, M., Larizadeh, M. H., Sabermahani, A., & Ghaderi, H. J. (2012). Markov's Modeling for Screening Strategies for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention, 13(10), 5125-5129. https://doi.org/10.7314/APJCP.2012.13.10.5125
Cenin, D. R., Naber, S. K., de Weerdt, A. C., Jenkins, M. A., Preen, D. B., Ee, H. C., O'Leary, P. C., & Biomarkers, P. (2020). Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History. Cancer Epidemiology, Biomarkers & Prevention, 29(1), 10-21. https://doi.org/10.1158/1055-9965.EPI-18-1123
Dinh, T., Ladabaum, U., Alperin, P., Caldwell, C., Smith, R., Levin, T. R. J. C. G., & Hepatology. (2013). Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer. Clinical Gastroenterology and Hepatology, 11(9), 1158-1166. https://doi.org/10.1016/j.cgh.2013.03.013
Greuter, M. J., Berkhof, J., Fijneman, R. J., Demirel, E., Lew, J.-B., Meijer, G. A., Stoker, J., & Coupé, V. M. J. C. (2016). The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. The British Journal of Radiology, 89(1063), 20150910. https://doi.org/10.1259/bjr.20150910
Haider, S., Chaikledkaew, U., Thavorncharoensap, M., Youngkong, S., Islam, M. A., & Thakkinstian, A. (2019). Systematic review and Meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries. Open Forum Infectious Diseases, 6(4), ofz117. https://doi.org/10.1093/ofid/ofz117
Hanly, P., Skally, M., Fenlon, H., & Sharp, L. (2012). Cost-effectiveness of computed tomography colonography in colorectal cancer screening: A systematic review. International Journal of Technology Assessment in Health Care, 28(4), 415-423. https://doi.org/10.1017/S0266462312000542
Heitman, S. J., Hilsden, R. J., Au, F., Dowden, S., & Manns, B. J. J. (2010). Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation. PLoS Medicine, 7(11), e1000370. https://doi.org/10.1371/journal.pmed.1000370
https://gco.iarc.fr/today/online-analysis
https://training.cochrane.org/handbook
Huang, W., Liu, G., Zhang, X., Fu, W., Zheng, S., Wu, Q., Liu, C., Liu, Y., Cai, S., & Huang, Y. (2014). Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations. PLoS ONE, 9(10), e109150. https://doi.org/10.1371/journal.pone.0109150
Issa, I. A., & Noureddine, M. (2017). Colorectal cancer screening: An updated review of the available options. World Journal of Gastroenterology, 23(28), 5086-5096. https://doi.org/10.3748/wjg.v23.i28.5086
Jakovljevic, M., Jakab, M., Gerdtham, U., McDaid, D., Ogura, S., Varavikova, E., Merrick, J., Adany, R., Okunade, A., & Getzen, T. E. (2019). Comparative financing analysis and political economy of noncommunicable diseases. Journal of Medical Economics, 22(8), 722-727. https://doi.org/10.1080/13696998.2019.1600523
Jeong, K. E., & Cairns, J. A. (2013). Review of economic evidence in the prevention and early detection of colorectal cancer. Health Economics Review, 3(1), 1-10. https://doi.org/10.1186/2191-1991-3-20
Khalili, F., Najafi, B., Mansour-Ghanaei, F., Yousefi, M., Abdollahzad, H., & Motlagh, A. (2020). Cost-effectiveness analysis of colorectal Cancer screening: A systematic review. Risk Management and Healthcare Policy, 13, 1499-1512. https://doi.org/10.2147/RMHP.S262171
Kingsley, J., Karanth, S., Revere, F. L., & Agrawal, D. J. (2016). Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study. PLoS ONE, 11(12), e0167452. https://doi.org/10.1371/journal.pone.0167452
Ladabaum, U., Allen, J., Wandell, M., Ramsey, S. J. C. E., & Biomarkers, P. (2013). Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies. Cancer Epidemiology, Biomarkers & Prevention, 22(9), 1567-1576. https://doi.org/10.1158/1055-9965.EPI-13-0204
Ladabaum, U., Alvarez-Osorio, L., Rösch, T., & Brueggenjuergen, B. (2014). Cost-effectiveness of colorectal cancer screening in Germany: Current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. Endoscopy International Open, 2(02), E96-E104. https://doi.org/10.1055/s-0034-1377182
Ladabaum, U., & Mannalithara, A. J. G. (2016). Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology, 151(3), 427, e426-439. https://doi.org/10.1053/j.gastro.2016.06.003
Ladabaum, U., Mannalithara, A., Meester, R. G., Gupta, S., & Schoen, R. E. J. G. (2019). Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. Gastroenterology, 157(1), 137-148. https://doi.org/10.1053/j.gastro.2019.03.023
Lam, C., Law, W., Poon, J., Chan, P., Wong, C., McGhee, S., & Fong, D. J. H. K. (2015). Health-Related Quality of Life in Patients with Colorectal Neoplasm and Cost-Effectiveness of Colorectal cancer Screening in Hong Kong. Hong Kong Medical Journal, 21(Suppl 6), 4-8.
Lansdorp-Vogelaar, I., Knudsen, A. B., & Brenner, H. (2010). Cost-effectiveness of colorectal cancer screening - an overview. Best Practice & Research. Clinical Gastroenterology, 24(4), 439-449. https://doi.org/10.1016/j.bpg.2010.04.004
Luhnen, M., Prediger, B., Neugebauer, E. A., & Mathes, T. J. S. (2017). Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied. Systematic Reviews, 6(1), 1-5. https://doi.org/10.1186/s13643-017-0639-8
Melnitchouk, N., Soeteman, D. I., Davids, J. S., Fields, A., Cohen, J., Noubary, F., Lukashenko, A., Kolesnik, O. O., & Freund, K. M. (2018). Cost-effectiveness of colorectal cancer screening in Ukraine. Cost Effectiveness and Resource Allocation, 16(1), 1-9. https://doi.org/10.1186/s12962-018-0104-0
Noordzij, M., Zoccali, C., Dekker, F. W., & Jager, K. J. (2011). Adding up the evidence: Systematic reviews and meta-analyses. Nephron. Clinical Practice, 119(4), c310-c316. https://doi.org/10.1159/000328914
Patel, S. S., & Kilgore, M. L. J. C. C. (2015). Cost Effectiveness of Colorectal Cancer Screening Strategies. Cancer Control, 22(2), 248-258. https://doi.org/10.1177/107327481502200219
Phisalprapa, P., Supakankunti, S., & Chaiyakunapruk, N. (2019). Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low-and middle-income country: Example from Thailand. Journal of Medical Economics, 22(12), 1351-1361. https://doi.org/10.1080/13696998.2019.1674065
Ran, T., Cheng, C.-Y., Misselwitz, B., Brenner, H., Ubels, J., & Schlander, M. (2019). Cost-effectiveness of colorectal Cancer screening strategies-A systematic review. Clinical Gastroenterology and Hepatology, 17(10), 1969-1981.e1915. https://doi.org/10.1016/j.cgh.2019.01.014
Sekiguchi, M., Igarashi, A., Matsuda, T., Matsumoto, M., Sakamoto, T., Nakajima, T., Kakugawa, Y., Yamamoto, S., Saito, H., & Saito, Y. J. J. (2016). Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: A cost-effectiveness analysis using Japanese data. Japanese Journal of Clinical Oncology, 46(2), 116-125.
Sekiguchi, M., Igarashi, A., Sakamoto, T., Saito, Y., Esaki, M., & Matsuda, T. J. (2020). Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score. Journal of Gastroentorology and Hepatology, 35(9), 1555-1561. https://doi.org/10.1111/jgh.15033
Sharaf, R. N., & Ladabaum, U. (2013). Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. American Journal of Gastroenterology, 108(1), 120-132.
Sharp, L., Tilson, L., Whyte, S., O'Ceilleachair, A., Walsh, C., Usher, C., Tappenden, P., Chilcott, J., Staines, A., Barry, M., & Comber, H. (2012). Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. British Journal of Cancer, 106(5), 805-816. https://doi.org/10.1038/bjc.2011.580
Skally, M., Hanly, P., & Sharp, L. (2013). Cost effectiveness of fecal DNA screening for colorectal cancer: A systematic review and quality appraisal of the literature. Applied Health Economics and Health Policy, 11(3), 181-192. https://doi.org/10.1007/s40258-013-0010-8
Telford, J. J., Levy, A. R., Sambrook, J. C., Zou, D., & Enns, R. A. J. C. (2010). The cost-effectiveness of screening for colorectal cancer. Canadian Medical Association Journal, 182(12), 1307-1313. https://doi.org/10.1503/cmaj.090845
Wong, C. K., Lam, C. L., Wan, Y., & Fong, D. Y. T. (2015). Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. British Medical Cancer, 15(1), 1-12. https://doi.org/10.1186/s12885-015-1730-y
Zhong, G. C., Sun, W. P., Wan, L., Hu, J. J., & Hao, F. B. (2020). Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: A systematic review and meta-analysis. Gastrointestinal Endoscopy, 91(3), 684-697 e615. https://doi.org/10.1016/j.gie.2019.11.035